Medicare Part B ASP Cost Savings Fall Below Government Expectations, Lawyer Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Congress is considering methods to improve cost savings from Part B reimbursement, Sidley Austin attorney says at International Pharmaceutical Compliance Summit in Philadelphia. Analysts note that the full impact of the average sales price-based Part B reimbursement is not yet evident.